Page last updated: 2024-08-23

diltiazem and methylprednisolone

diltiazem has been researched along with methylprednisolone in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (9.09)	18.7374
1990's	2 (9.09)	18.2507
2000's	10 (45.45)	29.6817
2010's	7 (31.82)	24.3611
2020's	1 (4.55)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Chen, X; Lin, X; Skolnik, S; Wang, J	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Neumayer, HH; Wagner, K	1
Neumayer, HH; Schreiber, M; Wagner, K	1
Baker, BA; Cacchione, JG	1
D'Ambrosio, A; Quintieri, F; Segoloni, G	1
Backman, JT; Kivistö, KT; Neuvonen, PJ; Varis, T	1
Hashimoto, Y; Tashima, K; Uchino, M; Uyama, E; Yonehara, T	1
Blum, RA; Booker, BM; Jusko, WJ; Lates, CD; Magee, MH	1
Mehta, M	1
Kurniawan, MZ; Lusida, M; Nugroho, J	1

Reviews

1 review(s) available for diltiazem and methylprednisolone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

4 trial(s) available for diltiazem and methylprednisolone

Article	Year
Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials. Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 10 Topics: Acute Kidney Injury; Adult; Cadaver; Clinical Trials as Topic; Cyclosporins; Diltiazem; Glomerular Filtration Rate; Graft Rejection; Humans; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Methylprednisolone; Prospective Studies; Random Allocation; Renal Circulation	1987
Prevention of delayed graft function by diltiazem and iloprost. Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 2 Topics: Clinical Trials as Topic; Cyclosporins; Diltiazem; Drug Therapy, Combination; Epoprostenol; Glomerular Filtration Rate; Humans; Iloprost; Kidney; Kidney Transplantation; Methylprednisolone; Prospective Studies; Random Allocation; Renal Circulation	1989
Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone. Clinical pharmacology and therapeutics, 2000, Volume: 67, Issue:3 Topics: Adrenal Glands; Adult; Anti-Inflammatory Agents; Antihypertensive Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Diltiazem; Double-Blind Method; Drug Synergism; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Mibefradil; Reference Values	2000
Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers. Clinical pharmacology and therapeutics, 2002, Volume: 72, Issue:4 Topics: Adult; Area Under Curve; Diltiazem; Drug Interactions; Drug Therapy, Combination; Humans; Hydrocortisone; Least-Squares Analysis; Male; Methylprednisolone; Middle Aged; Statistics, Nonparametric; T-Lymphocytes	2002

Other Studies

17 other study(ies) available for diltiazem and methylprednisolone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human. European journal of medicinal chemistry, 2009, Volume: 44, Issue:4 Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Dermatologic cross-sensitivity between diltiazem and amlodipine. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:1 Topics: Amlodipine; Diltiazem; Diphenhydramine; Drug Eruptions; Humans; Hydroxyzine; Male; Methylprednisolone; Middle Aged; Pruritus	1994
The modulatory effect of diltiazem on human in vitro alloreactivity when used alone or in combination with cyclosporin A and/or methylprednisolone. Transplant international : official journal of the European Society for Organ Transplantation, 1997, Volume: 10, Issue:6 Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Lymphocytes; Methylprednisolone	1997
Susac's syndrome: beneficial effects of corticosteroid therapy in a Japanese case. Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Asian People; Asthma; Ataxia; Brain; Cognition Disorders; Confusion; Diagnosis, Differential; Diltiazem; Drug Therapy, Combination; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Papilledema; Prednisone; Reflex, Abnormal; Retinal Artery; Retinal Artery Occlusion; Skin Diseases, Vascular; Syndrome; Ticlopidine; Vasculitis, Central Nervous System	2001
Drug incompatibility with methylprednisolone. Journal of neurosurgical anesthesiology, 2008, Volume: 20, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Antihypertensive Agents; Diltiazem; Drug Incompatibility; Hemangioma, Cavernous; Humans; Intraoperative Period; Male; Methylprednisolone; Spinal Cord Injuries; Spinal Cord Neoplasms	2008
Takayasu arteritis in a rural hospital in Indonesia. BMJ case reports, 2020, Jan-08, Volume: 13, Issue:1 Topics: Adolescent; Angiography; Antihypertensive Agents; Cyclosporine; Diagnosis, Differential; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Fever; Glucocorticoids; Hospitals, Rural; Humans; Immunosuppressive Agents; Indonesia; Methylprednisolone; Takayasu Arteritis	2020